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Transcription Factor Sp1 Is Essential
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Marisol Marin,* Alar Karis, Pim Visser, with the TATA-box protein accessory factor TAFII110
(Gill et al., 1994). When bound to distant sites in cis, itFrank Grosveld, and Sjaak Philipsen
can interact with itself, thus looping out the interveningErasmus University Rotterdam
DNA (Li et al., 1991; Su et al., 1991). This suggests thatDepartment of Cell Biology
Sp1 may establish interactions between promoters and3000 DR Rotterdam
distant regulatory elements in vivo through such a loop-The Netherlands
ing mechanism (Ptashne, 1986). Sp1 binding sites ap-
pear in numerous promoters and other regulatory se-
quences of tissue-specific and ubiquitous genes (overSummary
1500 citations).
A number of observations imply a wider role for Sp1-Transcription factor Sp1 has been implicated in the
like proteins in nuclear processes. Sp1 binding sites areexpression of many genes. Moreover, it has been
critical for the maintenance of the methylation-free CpGsuggested that Sp1 is linked to the maintenance of
island of the APRT gene (Brandeis et al., 1994; Macleodmethylation-free CpG islands, the cell cycle, and the
et al., 1994). Since Sp1 binding sites occur very fre-formation of active chromatin structures. We have in-
quently in CpG islands, this suggests that Sp1 preventsactivated the mouse Sp1 gene. Sp12/2 embryos are
methylation of many CpG islands in the genome. Mainte-retarded in development, show a broad range of ab-
nance of the appropriate methylation patterns is essen-normalities, and die around day 11 of gestation. In
tial for normal development (Li et al., 1992). A second
Sp12/2 embryos, the expression of many putative tar-
link between Sp1 and nuclear architecture is that Sp1
get genes, including cell cycle-regulated genes, is not may function in remodeling chromatin structures, as was
affected, CpG islands remain methylation free, and first observed for the SV40 virus early promoter (Jong-
active chromatin is formed at the globin loci. However, stra et al., 1984). Another example is the b-globin locus
the expression of the methyl-CpG-binding protein control region (LCR) (Grosveld et al., 1987) studied ex-
MeCP2 is greatly reduced in Sp12/2 embryos. MeCP2 tensively in our laboratory. The most important part of
is thought to be required for the maintenance of differ- the LCR, which can activate chromatin in single-copy
entiated cells. We suggest that Sp1 is an important transgenic mice (Ellis et al., 1996), is completely depen-
regulator of this process. dent on the presence of Sp1 binding sites (Philipsen et
al., 1993). Third, Sp1 has been implicated in the expres-
Introduction sion of cell cycle-regulated genes like thymidine kinase
(TK) (Karlseder et al., 1996), dihydrofolate reductase
Sp1 was one of the first eukaryotic transcription factors (DHFR) (Lin et al., 1996) and b-myb (Zwicker et al., 1996).
to be identified and cloned as a factor that binds to the It has been suggested that Sp1 activity is modulated by
SV40 early promoter (Dynan and Tjian, 1983). It contains components of the cell cycle machinery like the cyclins
three zinc finger motifs, Cys-2±His-2, which bind to a (Shao and Robbins, 1995) and Rb-like proteins (Shao
and Robbins, 1995), and Sp1 has been shown to interactconsensus GGG GCG GGG (Letovsky and Dynan, 1989).
directly with the growth- and cell cycle-regulated tran-Sp1 is an abundant nuclear protein in most cells, but
scription factor E2F in vitro (Karlseder et al., 1996; Linthe levelof expression changes duringdevelopment and
et al., 1996). Thus, Sp1 may be intricately linked to thevaries in different cell types (Saffer et al., 1991). Sp1 is
regulation of the cell cycle and the establishment ofthe founding member of a growing family of proteins
transcriptional competence through the maintenance ofwith highly homologous zinc-finger domains that bind
methylation-free islands and the organization of chro-GC or GT boxes (Hagen et al., 1992; Imataka et al., 1992;
matin structure, in addition to its direct role in transcrip-Kingsley and Winoto, 1992; Miller and Bieker, 1993;
tional activation.Crossley et al., 1996). This has precluded a straightfor-
In order to address these issues directly, we haveward interpretation of expression studies of putative
inactivated the mouse Sp1 gene in ES cells and charac-Sp1-responsive genes, and hence, little is known about
terized the phenotype of Sp1-deficient mice. Sp12/2 em-its biological role.
bryos survive until day 9.5 (E9.5) of gestation. They areThe molecular properties of Sp1 have been studied
severely retarded in growth and show a broad range ofin vitro in great detail. The protein is phosphorylated
phenotypic abnormalities. Sp12/2 ES cells contribute(Jackson et al., 1990) and highly glycosylated (Jackson
extensively to every tissue of chimeras until E9.5 but failand Tjian, 1988). The N-terminus contains glutamine-
to contribute after early embryonic development, thus
and serine/threonine-rich domains that are essential for
demonstrating that the defect in Sp12/2 cells is cell au-
transcriptional activation (Courey et al., 1989). The
tonomous. Furthermore, we show that in Sp12/2 em-
C-terminal domain of Sp1 is involved in synergistic acti- bryos the expression of many putative Sp1 target genes,
vation and interaction with other transcription factors including cell cycle-regulated genes, is unaffected, that
(Li et al., 1991). Sp1 has been shown to interact directly methylation-free islands are faithfully maintained, and
that the globin loci are activated, implying that active
chromatin structures can still be formed. However,*Present address: Universidad de Oviedo, Facultad de Medicina,
Sp12/2 embryos express the MeCP2 protein at 10-fold-Departamento de Bioquimica y Biologia Molecular, 33006 Oviedo,
Spain. reduced levels. The MeCP2 protein binds to methylated
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intact (see below). For clarity, we will refer to this deletionTable 1. Genotype Distribution of Sp1 Heterozygous Crossings
as a null mutation throughout this paper.
Stage Total 1/1 1/2 2/2 E14 ES cells were transfected with XhoI-digested tar-
E7.5 75 18 (24%) 43 (57%) 14 (19%) geting vector, and G418-resistant clones were analyzed
E8.5 137 35 (26%) 74 (54%) 28 (20%) for homologous recombination by Southern blotting
E9.5 143 34 (24%) 79 (55%) 30 (21%) (Figure 1B). Thirteen correctly targeted clones out of 36
E10.5 78 24 (31%) 36 (46%) 18 (23%) clones analyzed were further characterized by probing
E11.5 33 11 (33%) 18 (55%) 4 (12%)
with Bluescript to exclude additional random integrationPups 97 37 (38%) 60 (62%) 0 (0%)
events.
The genotype of embryos was determined by PCR analysis and
that of pups by Southern blotting, as described in Experimental
Mice Lacking Sp1 Die Early during EmbryogenesisProcedures. The observed distributions at E7.5±10.5 are not signifi-
Two Sp11/2 ES cell clones with the correct karyotypecantly different from the expected Mendelian 1:2:1 ratio (Chi-square
were injected into C57BL/6 blastocysts. High percent-test, p . 0.05), indicating that no loss of null embros occurs before
E10.5. age chimeras were obtained with both clones. Mating
of chimeric males with C57BL/6 and FVB females re-
sulted in germ-line transmission of the Sp1 knockout
DNA and is essential for normal embryonic development
allele. Results are shown in the C57BL/6 background,
but not for growth and differentiation of ES cells. Thus,
but they have been confirmed in the FVB background.
it has been proposed that MeCP2 is required for the
The F1 mice appeared to be normal; the F2 Sp11/2 mice
maintenance of differentiated cells (Tate et al., 1996).
were initially smaller than wild-type littermates, but no
We conclude that Sp1 is dispensable for growth and
other obvious abnormalities were found (data notdifferentiation of primitive cells and suggest that Sp1
shown). None of 97 live-born animals from heterozygousplays a role in the maintenance of differentiated cells
matings was homozygous for the Sp1 knockout (Tablethrough the regulation of genes like MeCP2.
1). Genotyping of embryos during earlier stages of devel-
opment by PCR (Figure 1C) showed no statistically sig-Results
nificant loss of Sp1-null embryos up to E10.5±11 (Table
1). Thus, Sp12/2 embryos survive until E9.5±10; byTargeted Disruption of the Sp1 Gene
E10.5±11, all of the Sp1-deficient embryos have died.The 39 end of the human Sp1 cDNA was used to isolate
There is a remarkable heterogeneity in phenotypegenomic cosmid clones of the mouse Sp1 gene. Six
(Figure 2). Frequently, 2/2 embryos had developed tooverlapping cosmids were isolated and used to con-
the 10±12 somite stage, while others in the same litterstruct the targeting vector (Figure 1A). The exons encod-
looked like a small undifferentiated mass of cells (Figureing the zinc-finger domains and the C-terminus (Kado-
2). Many structures and tissues can be recognized innaga et al., 1987; Chestier and Charnay, 1992) are
the advanced 2/2 embryos, e.g., somites, otic vesicle,replaced by a lacZ-neomycin (b-geo) fusion gene con-
limb bud, blood, the developing eye, and heart (Figuretaining a splice acceptor and the encephalomyelitis virus
2), indicating no specific developmental defect. How-internal ribosomal entry site (IRES) (Mountford et al.,
ever, 2/2 embryos are always much smaller than their1994), rendering expression of b-geo dependent on the
littermates, and their gross morphology does not corre-splice acceptor and translation from the IRES. This strat-
spond to any specific stage of normal mouse devel-egy results in the deletion of two important domains of
opment.the Sp1 protein: the DNA-binding zinc fingers and the
Hence, Sp12/2 embryos survive well beyond preim-C-terminus that is required for synergistic activation
(Courey et al., 1989). It leaves the 65 kDa N-terminus plantation, but importantly, Sp1 is absolutely essential
Figure 1. Targeted Disruption of the Sp1
Gene
(A) The 39 end of the mouse Sp1 gene. The
two exons (closed boxes) encoding the three
zinc fingers and the C-terminus of Sp1 are
replaced by a lacZ-neomycin fusion gene
(b-geo) in the targeting construct. The b-geo
gene contains a splice acceptor (SA), the pi-
cornaviral IRES, and SV40 polyadenylation
signals (not indicated) (Mountford et al.,
1994).
(B) Southern blot analysis of targeted ES
cells. DNA isolated from ES cell clones was
digested with PstI or BamHI, Southern blot-
ted, and hybridized with probe A or probe B
(panel [A]) as indicated. Probe A detects a
5.6 kb band (wild-type allele) or a 9.0 kb band
(targeted allele); probe B detects a 9.2 kb
band (wild-type allele) or an 8.6 kb band (tar-
geted allele).
(C) PCR analysis of mouse embryos. The
primers detect a 378 bp band for the wild-
type allele (wt; panel [A]) or a 690 bp band
for the targeted allele (Neo; panel [A]).
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this, we replaced b-geo in the targeting vector with a
hygromycin gene (Figure 3A). Sp11/2 ES cells were
transfected with this construct, and clones were picked
after hygromycin B selection (Figure 3B). Thirty out of
fifty-nine clones analyzed were homologous recombi-
nants, 14 at the wild-type allele and 16 at the already
targeted allele. Sp12/2 ES cells grew at normal rates in
standard ES cell media. Flow cytometry (Vindelov et al.,
1983) showed that the percentage of cells in G1, S, and
G21M phase of the cell cycle was the same for wild
type and Sp1-deficient ES cells (data not shown). The
absence of Sp1 DNA-binding activity was confirmed by
a gel-retardation analysis with ES cell protein extracts
(Figure 3C). The probe, derived from the SV40 early
promoter, bound Sp1 and Sp3 proteins present in nu-
clear extracts of wild type and 1\2 ES cells, as identified
by the presence of supershifts after the addition of Sp1-
or Sp3-specific antibodies. No DNA-binding Sp1 protein
is detected in 2/2 ES cells, while 1/2 ES cells show
reduced levels of Sp1 as compared to wild-type cells.
(Figure 3C).
However, the 65 kDa N-terminal domain is detectable
in 1/2 and 2/2 ES cells by Western blotting, but at
levels lower than those of full-length Sp1 (Figure 3D). The
N-terminal domain of Sp1 can act as a superactivator in
transient transfection assays; this activity is dependent
on overexpression of theN-terminus in combinationwith
DNA-binding Sp1. It is not observed when the Anten-
napedia activation domain is fused to the Sp1DNA bind-
ing domain (Courey et al., 1989) or in combination with
the closely related family member Sp3 (Hagen et al.,
1994). Therefore, the low expression level and the fact
that 1/2 animals develop normally exclude the likeli-
hood that the N-terminal domain acts as a gain-of-func-
tion or interfering mutation.
Thus, we have successfully targeted both alleles of
the Sp1 gene in ES cells. Surprisingly, the 2/2 cells
appear normal under standard tissue-culture condi-Figure 2. Phenotype of Sp1-Null Embryos at Different Develop-
tions, and they can be induced to differentiate and formmental Time Points
embryoid bodies as efficiently as control cells (data not(A) E7.5 embryos.
(B) E9 embryos. shown).
(C) E10 embryos. Note that the 2/2 embryo on the right has devel-
oped outside the yolk sac. The Defect in Sp12/2 Mice Is Cell Autonomous
(D) E11 embryos. Note that the 2/2 embryo had started to decom- It remained possible that certain tissues or cell types
pose at the time of dissection. Wild-type littermates of the 2/2
could develop normally from Sp1-deficient cells. To testembryos are shown on the left. White arrowheads indicate the pres-
this directly, we injected Sp12/2 ES cells into C57BL/6ence of erythroid cells in 2/2 embryos; the arrow points at the limb
bud of the E11 2/2 embryo (D). host blastocysts. Chimeric embryos were dissected at
(E and F) Phenotypic heterogeneity of Sp1-null embryos. (E) Four stages E9.5±11 (Figure 4). At E9.5, Sp12/2 ES cell contri-
embryos from one litter (E10) are shown. Left: heterozygous embryo. bution was detected in four out of five embryos (Figure
Right: three 2/2 embryos. (F) Heterozygous embryo at E8.5 (top) 4A, middle and right). Note that the E9.5 embryo with
compared with one of the 2/2 embryos shown in (E). Indicated are
the highest contribution of donor ES cells, as judgedthe developing eye (large white arrow), heart (black arrow), otic
by X-gal staining (Figure 4A, right), is morphologicallyvesicle (small white arrow) andsomites (between arrowheads). Origi-
nal magnifications are as indicated. similar to the Sp1-deficient embryo shown in Figure 2C,
left. Very few lacZ-positive cells could be detected in
any tissue of four embryos dissected at E10.5 (Figurefor normal embryogenesis. The broad range of abnor-
4B, left), while in the remaining three there was a modestmalities suggests that no particular cell lineage or devel-
contribution to random tissues (Figure 4B, middle andopmental process is affected but that Sp1-deficiency
right). At E11, a very limited contribution of the donorcauses a general cellular defect that precludes normal
ES cells was observed in three embryos (Figure 4C),development and survival.
while the remaining four were completely negative. Sev-
eral mice were analyzed 14 days after birth; they showedSp12/2 ES Cells Are Viable and Apparently Normal
no contribution of the Sp12/2 ES cells to the coat, norSince ES cells are derived from blastocysts and Sp1
to any other tissue analyzed by X-gal staining and PCRknockout embryos survive beyond this stage, we inacti-
vated the second allele in Sp11/2 ES cells. To achieve (data not shown).
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Figure 3. Generation of Sp1-Null ES Cells
(A) Sp11/2 ES cells were transfected with a
targeting vector similar to that described in
Figure 1A, except that the b-geo gene was
replaced with a hygromycin resistance gene
(hyg).
(B) Analysis of hygromycin-resistant ES cell
clones. The DNA was digested with BamHI,
Southern blotted, and hybridized with probe
B (Figure 1A). Random integrations (1/2, Neo
mutant), targeting at the already targeted al-
lele of the Sp1 gene (1/2, Hyg mutant), and
targeting at the remaining wild-type allele of
the Sp1 gene (2/2, Neo/Hyg mutant) are
shown. Fragment sizes are 8.6 kb for the
ªNeoº allele, 9.2 kb for the wild-type allele,
and 10.5 kb for the ªHygº allele.
(C) Gel-retardation analysis of Sp1 DNA-bind-
ing activity. Two micrograms of protein from
1/1, 1/2, or 2/2 ES cells was incubated
with an oligonucleotide probe containing ca-
nonical Sp1 binding sites (Philipsen et al.,
1990). The reaction products were electro-
phoresed through a 4% acrylamide/0.5 3
TBE gel. The specificity of protein±DNA com-
plexes is demonstrated by self competition
with a 100-fold molar excess of unlabeled
oligonucleotide as indicated. The identity of
complexes is revealed by the addition of anti-
bodies specific to Sp1 or Sp3, resulting in
slower migration of bands containing either
Sp1 or Sp3 (supershifts).
(D) Western blot analysis of 1/1, 1/2, and
2/2 ES cells. The positions of wild-type 90
kDa Sp1 and the 65 kDa N-terminus (N-term)
are indicated (top). The blot was reprobed
with an antibodyrecognizing the 89 kDa TFIIH
subunit to control for loading differences
(bottom).
We conclude that the defect in Sp12/2 cells is cell A large number of ubiquitous and tissue-specific
genes have been suggested to be regulated by Sp1autonomous. The cellsare intrinsicallyunable tocontrib-
ute to any tissue of the mouse after early embryonic (over 1500 publications). We analyzed the expression
of such potential target genes in ES cells (data notdevelopment, even when supported by wild-type cells
from the C57BL/6 host blastocysts. The results also shown) and E8.5 mouse embryos with RT±PCR. Expres-
sion analysis included cell cycle-regulated genes likeexclude that the primary defect is in the extraembryonic
tissues, since in chimeras these are derived from the APRT (Macleod et al., 1994), HPRT (Hornstra and Yang,
1992), DHFR (Birnbaum et al., 1995), and TK (Karlseder ethost blastocysts.
al., 1996); tissue-restricted genes like the LDL receptor
(Koivisto et al., 1994) and Apolipoprotein A1 (ApoA1)
Expression of Putative Sp1 Target Genes (Lamon2Fava et al., 1992); and the tissue-specific
Preliminary data obtained with electron microscopy a- and b-like globins (Yu et al., 1991; Philipsen et al.,
suggested that Sp12/2 embryos might suffer from a de- 1993). collagen aIV was used as a control, since Sp1
fect in lipid metabolism or the lysosomal compartment has not been implicated in the regulation of this gene.
(data not shown). Therefore, we checked the expression As shown in Figure 5, the expression of most of these
of proteins involved in lipid metabolism (ALDR, ApoE, genes is not affected in Sp12/2 embryos with the excep-
ApoAII, CAT, ScoAD, HMG-CoA reductase) and lyso- tion of the TK gene, which is 2- to 3-fold reduced in the
somal enzymes (b-galactosidase, a-fucosidase, a-galac- 2/2 embryos (Figure 5A).
tosidase, a-iduromidase, a-N-acetylgalsctosaminidase, The expression levels of the LDL receptor and ApoA1
b-glucuromidase, b-glucosidase, b-hexosaminidaseA, genes are indistinguishable between the wild-type, het-
b-mannosidase), but none of these was affected (data erozygous, and homozygous mice (Figure 5B). The em-
bryonic a-globin (Zeta) and b-globins (bH1 and eY) arenot shown).
Sp1 Is Essential for Embryonic Development
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Figure 4. Contribution of Sp12/2 ES Cells to
Chimeric Embryos
C57BL/6 host blastocysts were injected with
12±14 Sp12/2 ES cells and transferred into
foster mothers. Embryos were dissected at
stages E9.5, E10.5, and E11, fixed, and
stained with X-gal to reveal the presence of
Sp12/2 cells.
(A) Embryos at E9.5. Five embryos were ana-
lyzed, of which one had no detectable contri-
bution of the donor ES cells (left). Note the
correlation between the severity of the phe-
notype and the contribution of 2/2 ES cells
to the embryo as revealed by X-gal staining
(middle and right).
(B) Embryos at E10.5. Seven embryos were
analyzed, four of which contained hardly any
LacZ-positive cells (left). Embryos containing
detectable amounts of X-gal-positive cells
(middle and right) are retarded in develop-
ment relative to those showing no staining
(left).
(C) Embryos at E11. Contribution of the donor
ES cells could not be detected in four of the
seven embryos analyzed;a small contribution
was observed in the remaining three (shown).
Magnifications are as indicated.
less abundant in the knockout mice than in wild-type methylation-insensitive HpaII isoschizomer MspI (Figure
6B). No significant difference in the methylation of theor heterozygous mice (Figure 5C), but they are still ex-
HpaII and SmaI sites in the APRT CpG island was ob-pressed at significant levels, suggesting that the chro-
served between 1/1, 1/2, and 2/2 Sp1 ES cells. Inmatin of the globin loci is activated in Sp12/2 erythroid
fact, the SmaI digest reveals some methylation of thecells. Hence, Sp1 does not appear to be essential for
island in the control cells but not in 1/2 or 2/2 cells.expression of these genes in E8.5 mouse embryos.
Since the APRT gene is dispensable under tissue-cul-Taken together, the data show that many putative Sp1
ture conditions (She and Taylor, 1995), it is unlikely thattarget genes are expressed normally in Sp12/2 mice,
these results can be simply explained by positive selec-implying that the number of genes critically dependent
tion for APRT-expressing ES cells.on the presence of Sp1 is much smaller than expected.
Next, we examined CpG islands in E9.5 Sp1-deficient
embryos. Since only very small quantities of DNA could
be obtained from individual Sp12/2 embryos, we pooledMethylation Status of CpG Islands
these samples and performed a methylation analysis ofRecent transgenic mice experiments have shown that
the APRT CpG island by PCR (Kafri et al., 1992) withSp1 binding sites are essential to maintain the methyla-
HpaII- or MspI-digested DNA samples from 1/1, 1/2,tion-free status of the CpG island of the APRT gene,
and 2/2 embryos. As shown in Figure 6C, the fragmentsuggesting that Sp1 is required to prevent methylation
corresponding to the methylation-free island could onlyof CpG islands in mammals (Brandeis et al., 1994; Mac-
be amplified in undigested DNA. These results are con-
leod et al., 1994). We tested this hypothesis in Sp1-
sistent with those obtained in ES cells (Figure 6B) and
null mutant ES cells and mice. DNA from wild-type and
show that the methylation-free island of the APRT gene
single- and double-knockout ES cells was digested with
is not affected by the knockout. As a control, we ampli-
the methylation-sensitive enzymes SmaI and HpaII, end
fied a region of the APRT gene that is known to be
labeled, size fractionated,and autoradiographed (Figure methylated (Macleod et al., 1994). An APRT-specific
6A). Because the bulk DNA is heavily methylated and band was found in the HpaII-digested DNA samples but
contains relatively few HpaII and SmaI sites, it is cut not in the samples that had been cut with MspI. Hence,
infrequently. However, CpG islands are normally un- CpG methylation outside the island region appears to
methylated, contain many HpaII and SmaI sites, and be normal in the Sp12/2 mice. In addition, we checked
therefore are cut frequently by these enzymes. This frac- the methylation status of the CpG islands in the DHFR
tion of DNA, known as the HpaII tiny fragments (HTF) (Kafri et al., 1992) and ApoA1 (Shemeret al., 1991) genes.
(Cooper et al., 1983), is seen as a low molecular weight As shown in Figure 6C, there was no amplification of
smear on an agarose gel after end labeling of the digest island-specific PCR products except in the uncut DNA,
(Figure 6A). Since we observe no difference in the HTF indicating that the HpaII sites in the DHFR CpG island
fraction of DNA from 1/1, 1/2, and 2/2 cells (Figure and the HhaI sites in the ApoA1 CpG island of 1/1,
6A), we conclude that many, if not all, methylation-free 1/2, and 2/2 embryos are not methylated. From these
islands are faithfully maintained in Sp1-deficient ES results we conclude that Sp1 is not generally required
cells. In addition, we examined the methylation status to maintain the methylation-free status of mammalian
of the CpG island for the APRT gene (Brandeis et al., CpG islands.
To investigate further the potential link between Sp11994; Macleod et al., 1994) using SmaI, HpaII, and the
Cell
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Figure 5. Expression of Putative Sp1 Target
Genes
RNA was isolated from individual E8.5 em-
bryos, cDNAs were synthesized, and the ex-
pression of putative target genes was ana-
lyzed by PCR. Samples were taken after
variable numbers of cycles and analyzed by
electrophoresis on 1.5% agarose gels.
cDNAs were analyzed in duplicate for three
different embryos of each genotype (wild
type, 1/2, or 2/2).
(A) Expression of cell cycle-regulated genes
(APRT, DHFR, TK, HPRT). These genes are
also known as typical ªhousekeepingº genes.
Expression of the TK gene is reduced in 2/2
embryos, while expression of the other genes
is not affected.
(B) Expression of the tissue-restricted ApoAI
and LDLR genes. No significant differences
are detected between the samples.
(C) Expression of embryonic globin genes. The b-like (bH1 and eY) and a-like (Zeta) globin genes are expressed at lower levels in the Sp12/2
embryos.
(D) Expression of the collagen aIV gene was used to standardize the PCR assay. In agreement with the data shown in Figure 3C, expression
of the C-terminal part of the Sp1 gene is reduced in 1/2 and undetectable in 2/2 embryos.
and DNA methylation, we analyzed the expression of reflect a general function for Sp1 in every cell type,
consistent with its ubiquitous expression pattern (Saffertwo genes associated with DNA methylation, DNA meth-
yltransferase (Li et al., 1992) and MeCP2 (Lewis et al., et al., 1991). Frequently observed abnormalities in
Sp12/2 embryos are asymmetry along the body axis,1992). It should be noted that these genes are essential
for embryonic developmentand that the null phenotypes incomplete turning, and growth outside the yolk sac.
Interestingly, the differentiative capacity of Sp12/2 cellsare reminiscent of the Sp12/2 phenotype (Li et al., 1992;
Tate et al., 1996). The DNA methyltransferase protein does not appear to be severely impeded, since we ob-
serve many of the structural hallmarks of normal E8.5±methylates C residues at CpG dinucleotides. As shown
in Figure 7A, this gene is expressed at normal levels 9.5 embryos in the best-developed 2/2 embryos.
From the large number of putative Sp1 target genes,in Sp12/2 mice, consistent with the DNA methylation
analysis shown in Figure 6, which suggested that overall it might have been predicted that inactivation of Sp1
would be incompatible with cellular growth and differen-DNA methylation is not affected by the Sp1 knockout.
While the MeCP2 protein has no known enzymatic activ- tiation and thus result in very early preimplantation le-
thality. However, we show that many putative targetity, it binds specifically to methylated CpGs without any
other apparent sequence specificity and is mainly local- genes are expressed at normal levels in Sp12/2 mice.
We suggest that other members of the Sp1 family, likeized to heterochromatin, which is known to be highly
methylated in the mouse (Lewis et al., 1992); it might the closely related Sp3 protein (Hagen et al., 1992; Ima-
taka et al., 1992; Kingsley and Winoto, 1992), may com-function as a transcriptional repressor (Nan et al., 1997).
Interestingly, we find that the expression level of the pensate at least in part for the loss of Sp1 activity,
ameliorating the effect of the Sp1 knockout. DespiteMeCP2 gene is 2-fold lower in heterozygous and hardly
detectable in homozygous Sp1 knockout embryos (Fig- this potential for overlapping or compensatory functions
early in embryogenesis, our data demonstrate that Sp1-ure 7B). Since the RT±PCR assay is indirect, we per-
formed a gel-retardation analysis to quantitate the levels dependent gene activation is absolutely essential for
normal mouse development.of MeCP2 protein (Figure 7C). This analysis shows that
the level of MeCP2 protein is reduced 2- to 3-fold in
heterozygous and more than 20-fold in 2/2 embryos. Sp1 and Nuclear Architecture
Transgenic mouse experiments investigating the CpGTogether, these data suggest that MeCP2-deficiency
contributes significantly to the Sp12/2 phenotype. island of the APRT gene have suggested that Sp1 plays
a role in the maintenance of methylation-free islands
(Brandeis et al., 1994; Macleod et al., 1994). We haveDiscussion
tested this hypothesis in Sp12/2 ES cells and embryos.
Our analyses show that the methylation-free status ofTargeted Disruption of the Sp1 Gene
In this paper, we describe the targeted inactivation of CpG islands in general, and that of the APRT island in
particular, are faithfully maintained. Since integrity ofthe mouse gene encoding transcription factor Sp1. Our
results demonstrate that Sp1 is essential for normal Sp1 binding sites is required to keep the APRT island
unmethylated (Brandeis et al., 1994; Macleod et al.,mouse embryogenesis. Sp12/2 embryos are found in
normal numbers during early embryonic development, 1994), we suggest that the binding of other family mem-
bers may be sufficient to maintain the methylation-freebut they all die around day 11 of gestation. The knockout
embryos are severely retarded in development and dis- status. The Sp3 protein would be an attractive candidate
because of its ubiquitous expression pattern and itsplay a marked heterogeneity in phenotype. This might
Sp1 Is Essential for Embryonic Development
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Figure 7. Expression of DNA Methyltransferase and MeCP2 in
Sp12/2 Embryos
RT±PCR was performed as described for Figure 5. HPRT served as
an internal control in the amplification reactions.
(A) Expression of DNA-methyltransferase.
(B) Expression of MeCP2. The amplification products were sepa-
rated on 1.5% agarose gels, Southern blotted, and hybridized with
the oligonucleotides used for PCR (bottom).
(C) Gel-retardation analysis of MeCP2 protein in 1/1, 1/2, and
2/2 E9.5 mouse embryos. The top part of the gel is shown. Extracts
were made of three combined 2/2 embryos or individual 1/1 and
Figure 6. DNA Methylation in Sp1-Null ES Cells and Embryos 1/2 embryos as indicated. Ten percent of the 2/2 extracts was
used per reaction; theamount of extract was calibrated using probes(A) DNA was isolated from wild-type, 1/2, and 2/2 ES cells, di-
binding Sp3or Oct-1 (data not shown). Probes shown are an oligonu-gested with the methylation-sensitive enzymes HpaII or SmaI, end
cleotide containing five symmetrically methylated CpGs (MeCP2)labeled with [a-32P]dCTP, and electrophoresed on a 2% agarose
and the Sp1 binding site (Figure 3C). The complex was identifiedgel. The fraction containing the methylation-free islands, known as
as MeCP2 through (i) competition with a 100-fold molar excess ofthe HpaII tiny fragments (HTF) fraction (Cooper et al., 1983), is indi-
oligonucleotides with 5 or 12 symmetrically methylated CpGs butcated. The marker is pUC19 digested with MspI.
not with nonmethylated versions of the same oligonucleotides (left);(B) DNA isolated from wild-type, 1/2, and 2/2 ES cells was di-
(ii) competition with eukaryotic DNA containing methylated CpGsgested with the methylation-sensitive enzymes HpaII or SmaI, or
but not with E. coli DNA lacking methylated CpGs (data not shown);with the methylation-insensitive HpaII isoschizomer MspI. The di-
and (iii) supershifts with the MeCP2 antibody #674 (left) (no su-gested samples were run on a 1% agarose gel, Southern blotted,
pershifts are observed with the methylated probe alone or in unre-and hybridized to detect the methylation-free island of the APRT
lated bandshift reactions [data not shown]). Quantization of MeCP2-gene (Macleod et al., 1994). Fragment sizes are indicated on the
binding activity is as follows (the wild-type level is arbitrarily set atright.
1): 1/1, 1.00; 1/2, 0.34; 2/2, 0.04.(C) DNA was isolated from wild-type, 1/2, or 2/2 E9.5 embryos
and digested with HpaII, HhaI, or MspI. The samples were subjected
to PCR amplification to reveal the methylation status of individual
CpG islands (APRT, DHFR, ApoAI) (Kafri et al., 1992). A fragment the LCR, which contains 6 functional Sp1 binding sites
of the c-kit gene lacking HpaII and HhaI sites was used as an internal
(Philipsen et al., 1990). Importantly, 59HS3 is the onlycontrol for the amplification reaction. Note that for the ApoAI gene
LCR element capable of activating single-copy trans-this control was done in a separate reaction because the c-kit and
genes in mice (Ellis et al., 1996). The chromatin structureApoAI fragments comigrate; the ApoAI island does not contain HpaII
sites. A region of the APRT gene containing three partially methyl- at 59HS3 and the b-globin promoter is correctly remod-
ated HpaII sites was amplified as a control for the detection of eled in erythroid cells of these mice, suggesting that
methylation (nonisland APRT) (Macleod et al., 1994). All the samples Sp1-like proteins are directly involved in chromatin
were redigested with the appropriate enzymes to show that the
opening. The phenotype of mice null for the erythroid-digests were complete (data not shown).
specific Sp1 family member EKLF (Nuez et al., 1995;
Perkins et al., 1995) is consistent with this notion. These
mice die of failure to express the b-major gene, and thestructural similarity to Sp1 (Hagen et al., 1992; Kingsley
and Winoto, 1992). DNase I hypersensitive site at thepromoter is not formed
(Nuez et al., 1995; Perkins et al., 1995; Wijgerde et al.,Our work on the human b-globin LCR has shown that
Sp1binding sitesare essential for LCR activity (Philipsen 1996). Interestingly, the embryonic b- and a-globin
genes are expressed normally, suggesting that otheret al., 1990; 1993). This is best illustrated by 59HS3 of
Cell
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Sp1-family members are involved. Since erythropoiesis al., 1993; Gu et al., 1994) of the Sp1 gene will be required
to address the role of Sp1 in fully developed tissues. Inin Sp12/2 mice is not severely affected, Sp1 does not
appear to be a key activator of the erythroid program, addition, such mice will be a valuable tool to establish
the role of Sp1 in the maintenance of terminally differen-at least in the embryonic stage.
Thus, our data do not support models in which Sp1 tiated cells.
plays a pivotal role in the organization and maintenance
Experimental Proceduresof nuclear architecture.
Construction of the Targeting Vectors
A 129 mouse cosmid genomic DNA library was screened with aSp1 May Be Required for the Maintenance
probe spanning nucleotides 1820±2103 of pSp1±778c (Kadonaga
of Differentiated Cells et al., 1988) corresponding to the C-terminal end of Sp1.Six overlap-
We have shown that Sp12/2 ES cells can contribute ping cosmids were isolated containing two exons encoding the zinc
extensively to every tissue of E9.5 chimeras but not fingers and the C-terminus of Sp1. The neomycin targeting vector
(pBSp1/Neo) is a promoterless construct containing 2 kb 59 and 3.7to later embryonic time points or newborn mice. This
kb 39 regions of homology to the Sp1 gene in pBS II KS. The b-geosuggests that Sp1-deficiency causes a cellular defect
cassette containing a splice acceptor and the picornaviral IRESand cell death only after commitment and/or differentia-
(Mountford et al., 1994) replaces the 2 kb NcoI fragment with the
tion have occurred. Thus, it could be predicted that two exons encoding the zinc fingers and C-terminus of Sp1 (Figure
the expression of genes linked to cellular maintenance 1). The hygromycin targeting vector (pBSp1/hyg) was constructed
would be reduced in the knockout. from pBSp1/Neo by replacing the NcoI-SmaI fragment containing
the b-geo gene with a hygromycin gene (Figure 3).We have identified two genes that are expressed at
a lower level in Sp12/2 embryos, the TK gene and the
Transfection and Analysis of ES CellsMeCP2 gene. The significance of the lower expression
E14 ES cells were cultured as described (Nuez et al., 1995). Clones
of the TK gene is not clear at the moment, in particular were selected, after electroporation with 15 mg of XhoI-linearized
since other cell cycle-regulated genes are not affected, targeting vector pBSp1/Neo or pBSp1/hyg, with G418 (200 mg/ml)
and Sp12/2 ES cells have normal growth rates and cell or with hygromycin B (160 mg/ml) as appropriate. Homologous re-
combination was analyzed by Southern blotting using two externalcycle distribution. In contrast, the reduced expression
probes flanking the left and right homologous arms (Figure 1). Aof the MeCP2 protein is very likely to contribute directly
pBS probe was used to detect random integrations in the genome.to the phenotype of Sp12/2 mice. The MeCP2 gene is
X-linked, and for this reason, the analysis of the pheno-
Generation of Chimeric and Sp1-Deficient Mice
type of the MeCP2 knockout has been limited to studies Two independent Sp11/2 targeted clones were microinjected in
in ES cell-differentiation assays and chimeric embryos C57BL/6 host blastocysts, and male chimeras with more than 80%
contribution of ES cells to the coat were mated with C57BL/6 and(Tate et al., 1996). ES cells lacking MeCP2 grow and
FVB females. Germline transmission was analyzed by Southern blotdifferentiate normally. They contribute to every tissue
analysis of tail DNA. Sp12/2 ES clones were injected in C57BL/6of the early mouse embryo but fail to make a significant
blastocysts. Embryos were dissected at E9.5±11, fixed in 0.5% glu-contribution to the newborn animal. Moreover, embryos
taraldehyde/1% formaldehyde in PBS, and stained with X-gal to
with a high proportion of MeCP22 cells are retarded and identify lacZ-positive cells derived from the 2/2 ES cells (Bonnerot
unable to develop normally (Tate et al., 1996), as is found and Nicolas, 1993).
for embryos with a high contribution of Sp12/2 cells
Genotyping of Embryos(Figure 4A). Thus, there are striking similarities between
Embryos from heterozygous matings were dissected, and a smallthe phenotypes of the MeCP2 and Sp1 knockouts.
part of the embryo was used for PCR analysis, as described, (GurtnerMeCP2 is not a transcription factor in the classical
et al., 1995) using three primers: an antisense primer in the Sp1 gene
sense, but it might perform a structural role in the nu- (59-TTGGACCCATGCTACCTTGC-39), a sense primer amplifying the
cleus and act as a transcriptional repressor. In wild-type wild-type allele (59-AATTTGCCTGCCCTGAGTGC-39; 378 bp prod-
mice, the amount of MeCP2 is limiting relative to the uct), and a sense primer in the Neo gene amplifying the targeted
allele (59-GCGCATCGCCTTCTATCG-39; 690 bp product). PCR wasnumber of binding sites (Nan et al., 1997). Hence, the
done for 30 cycles (948C, 1 min; 608C, 1 min; 728C, 1 min).much lower level of MeCP2 found in Sp12/2 mice could
be predicted to have an effect similar to the MeCP2
Gel Mobility-Shift Assays
knockout. Interestingly, the levels of Sp1 (Saffer et al., Two micrograms of nuclear protein extracts from wild type and
1991) and MeCP2 (Tate et al., 1996) increase during mutant ES cells or E9.5 embryos (Andrews and Faller, 1991) was
development, and there is a significant (2- to 3-fold) used per reaction in gel mobility shifts (Wall et al., 1988) using the
dimer Sp1 binding site from the SV40 early promoter (Philipsen etreduction of MeCP2 protein in heterozygous embryos,
al., 1990). Sp1- and Sp3-specific antibodies were kindly provided byconsistent with the notion of a close genetic interaction
Dr. Guntram Suske (Marburg). Gel mobility-shift assays for MeCP2between Sp1 and MeCP2. It has been proposed that
(Lewis et al., 1992) contained 0.5 ng of labeled oligonucleotide with
MeCP2 is required for the survival of differentiated cells 5 symmetrically methylated CpGs, 50 ng of cold nonmethylated
(Tate et al., 1996), and thus we suggest that MeCP2- version of the oligonucleotide, and protein extract. The gels were
deficiency contributes significantly to the phenotype of quantitated by PhosphorImage analysis. MeCP2-specific antibody
#674 was a kind gift of Drs. Xinsheng Nan and Adrian Bird (Edin-Sp12/2 embryos.
burgh). Methylated oligonucleotides were synthesized by Isogen BVIt should be emphasized that there have to be many
(Maarssen NL).more Sp1 target genes than the MeCP2 and TK genes
identified in this paper. The early embryonic lethality of
Western Blotting
the mice described here, long before organogenesis Thirty micrograms of protein per lane was separated on a 10%
has been completed, precludes an exhaustive survey SDS±PAGE gel, blotted on a PVDF membrane, and probed with a
rabbit polyclonal antibody recognizing Sp1 or a mouse monoclonalof these target genes. Conditional inactivation (Kilby et
Sp1 Is Essential for Embryonic Development
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antibody recognizing the 89 kDa subunit of TFIIH (a kind gift of Dr. and Orkin, S.H. (1996). Isolation and characterization of the cDNA
encoding BKLF/TEF-2, a major CACCC-box-binding protein in ery-Jean-Marc Egly, Strassbourg). The Sp1 antibody recognizes the
N-terminus of Sp1 that has not been deleted in the knockout. Bands throid cells and selected other cells. Mol. Cell. Biol. 16, 1695±1705.
were visualized using peroxidase-conjugated secondaryantibodies. Dynan, W.S., and Tjian, R. (1983). Isolation of transcription factors
that discriminate between different promoters recognized by RNA
DNA Methylation Analysis polymerase II. Cell 32, 669±680.
DNA from ES cells or pooled embryos was digested with HhaI, SmaI, Ellis, J., Tanun, K.C., Harper, A., Michalovich, D., Yannoutsos, N.,
HpaII, or MspI. ES cell DNA was end labeled with [a-32P]dCTP and Philipsen, S., and Grosveld, F. (1996). A dominant chromatin-open-
run on a 2% agarose gel to reveal the fraction containing the methyl- ing activity in 59 hypersensitive site 3 of the human beta-globin locus
ation-free islands (Cooper et al., 1983). The methylation status of control region. EMBO J. 15, 562±568.
the APRT methylation-free island was analyzed as described (Mac-
Gill, G., Pascal, E., Tseng, Z.H., and Tjian, R. (1994). A glutamine-leod et al., 1994). In DNA from mouse embryos, the methylation
rich hydrophobic patch in transcription factor Sp1 contacts thestatus of the APRT, DHFR, and ApoAI islands was analyzed by PCR
dTAFII110 component of the Drosophila TFIID complex and medi-(Kafri et al., 1992). As a control for DNA methylation, we amplified
ates transcriptional activation. Proc. Natl. Acad. Sci. USA 91,a region in the APRT gene containing three HpaII sites that are
192±196.known to be partially methylated (Macleod et al., 1994). As a control
Grosveld, F., van Assendelft, G.B., Greaves, D.R., and Kollias, G.for the PCR reactions, we amplified a fragment of the c-kit gene
(1987). Position-independent, high-level expression of the humanlacking HpaII and HhaI sites. PCR reactions were carried our for 30
b-globin gene in transgenic mice. Cell 51, 975±985.cycles (948C, 1 min; 558C, 1 min; 728C, 1 min) with ,100 ng of
genomic mouse DNA. Gu, H., Marth, J.D., Orban, P.C., Mossmann, H., and Rajewsky, K.
(1994). Deletion of a DNA polymerase beta gene segment in T cells
using cell type-specific gene targeting. Science 265, 103±106.Gene-Expression Analysis by RT±PCR
Total RNA was isolated from E8.5 embryos and used as a template Gurtner, G.C., Davis, V., Li, H., McCoy, M.J., Sharpe, A., and Cybul-
for reverse transcription primed by oligo(dT). One-fiftieth of the syn- sky, M.I. (1995). Targeted disruption of the murine VCAM1 gene:
thesized cDNA was used for PCR (948C, 30 s; 558C, 30 s; 728C, 45 essential role of VCAM-1 in chorioallantoic fusion and placentation.
s), and aliquots were taken after variable numbers of cycles. The Genes Dev. 9, 1±14.
amplified fragments were visualized on 1.5% agarose gels, Southern Hagen, G., Muller, S., Beato, M., and Suske, G. (1992). Cloning by
blotted, and hybridized with the oligonucleotides used in the PCR recognition site screening of two novel GT box binding proteins: a
for quantization by PhosphorImage analysis. family of Sp1 related genes. Nucleic Acids Res. 20, 5519±5525.
The primer sets used to amplify CpG islands and cDNAs, the sizes
Hagen, G., Muller, S., Beato, M.,and Suske, G. (1994). Sp1-mediatedof the amplification products, gel-retardation probes, and more de-
transcriptional activation is repressed by Sp3. EMBO J. 13, 3843±tailed experimental procedures are available upon request via e-mail
3851.(philipsen@CH1.Fgg.EUR.NL).
Hornstra, I.K., and Yang, T.P. (1992). Multiple in vivo footprints are
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